Epidemiological profile of deaths from cystic fibrosis in Brazil between 2012 and 2022 based on data from the repository of the Department of Information Technology of the Unified Health System (DataSUS)
DOI:
https://doi.org/10.33448/rsd-v13i10.46903Keywords:
Cystic fibrosis; Health profile; Mortality.Abstract
Introduction: Cystic fibrosis is an autosomal recessive hereditary disease that mainly affects the respiratory system and gastrointestinal tract, and those with this comorbidity may die due to its complications. Objective: This study aims to describe the epidemiological characteristics of deaths from cystic fibrosis in Brazil between 2012 and 2022. Methodology: This is a cross-sectional study, in which the researchers analyzed data available in the Mortality Information System (SIM), of the Department of Information Technology of the Unified Health System (DataSUS). Results: According to the variables investigated, the results found point to the year 2022 with the highest percentage of deaths due to cystic fibrosis with 11.99% (n = 291), a higher prevalence of females, representing 50.87% (n = 1,234), in the age group of 80 years or older, with 16.24% (n = 394), white, with 59.73% (n = 1,449), and the Southeast Region and city of São Paulo, presenting 43.56% (n = 1,057) and 22.63% (n = 549) of total deaths, respectively. Conclusion: Thus, we highlight the importance of encouraging the expansion of health policies for the treatment of individuals with cystic fibrosis, aiming to reduce the number of deaths from this disease in Brazil.
References
BRASIL. Ministério da Saúde. (2016). Secretaria de Atenção A Saúde. Traigem neonatal biológica-Manual Técnico.Brasilia: Ministério da Saúde.
BRASIL. (2016). Resolução n°510, de 7 de abril de 2016. Diário Oficial da União. Ministério Da Saúde.
De Boeck K. (2020). Cystic fibrosis in the year 2020: a disease with a new face. Acta Paediatrica (Oslo, Norway: 1992), 109(5), 893–899. https://doi.org/10.1111/apa.15155
Galante, G., & Freeman, A. J. (2019). Gastrointestinal, pancreatic, and hepatic manifestations of cystic fibrosis in the newborN. Neoreviews, 20(1), e12–e24. https://doi.org/10.1542/neo.20-1-e12
Gil, AC (2002). Como elabora projetos de pesquisa/Antônio Carlos Gil. (4a ed.), Atlas.
Grasemann, H., & Ratjen, F. (2013). Early lung disease in cystic fibrosis. The Lancet. Respiratory Medicine, 1(2), 148–157. https://doi.org/10.1016/s2213-2600(13)70026-2
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022). Aging and aging-related diseases: from molecular mechanisms to interventions and treatmentS. Signal Transduction and Targeted Therapy, 7(1), 391. https://doi.org/10.1038/s41392-022-01251-0
Halliburton, C. S. (1996). Cystic fibrosis deaths in the united states from 1979 through 1991. Archives Of Pediatrics & Adolescent Medicine, 150(11), 1181. https://doi.org/10.1001/archpedi.1996.02170360071012
Hunt, X., Hameed, S., Tetali, S., Ngoc, L. A., Ganle, J., Huq, L., Shakespeare, T., Smythe, T., Ilkkursun, Z., Kuper, H., Acarturk, C., Kannuri, N. K., Mai, V. Q., Khan, R. S., & Banks, L. M. (2023). Impacts of the COVID-19 pandemic on access to healthcare among people with disabilities: evidence from six low- and middle-income countries. International journal for equity in health, 22(1), 172. https://doi.org/10.1186/s12939-023-01989-1
IBGE. Instituto Brasileiro de Geografia e Estatística. (2022). Panorama Censo 2022. https://censo2022.ibge.gov.br/panorama/
Khan, M. A., Ali, Z. S., Sweezey, N., Grasemann, H., & Palaniyar, N. (2019). Progression of cystic fibrosis lung disease from childhood to adulthood: neutrophils, Neutrophil Extracellular Trap (NET) formation, and net degradation. Genes, 10(3), 183. https://doi.org/10.3390/genes10030183
Myer, H., Chupita, S., & Jnah, A. (2023). Cystic fibrosis: back to the basics. Neonatal Network: NN, 42(1), 23–30. https://doi.org/10.1891/nn-2022-0007
McBennett, K. A., Davis, P. B., & Konstan, M. W. (2022). Increasing life expectancy in cystic fibrosis: Advances and challenges. Pediatric pulmonology, 57 Suppl 1(Suppl 1), S5–S12. https://doi.org/10.1002/ppul.25733
Rafeeq, M. M., & Murad, H. A. S. (2017). Cystic Fibrosis: Current Therapeutic Targets and Future Approaches. Journal Of Translational Medicine, 15(1), 84. https://doi.org/10.1186/s12967-017-1193-9
Rosa, F. R., Dias, F. G., Nobre, L. N., & Morais, H. A. (2008). Fibrose Cística: Uma Abordagem Clínica E Nutricional. Revista De Nutrição, 21(6), 725–737. https://doi.org/10.1590/s1415-52732008000600011
Reis, F. J. C. & Damaceno, N. (1998). Fibrose cística. Jornal De Pediatria.71(1), 76-94. 10.2223/JPED.489
Reis, F. J. C., Oliveira, M. C. L., Penna, F. J., M. Das, Oliveira, G. R. & Monteiro, A. P. A. F. (2000). Quadro clinico e nutricional de pacientes com fibrose cística: 20 annos de seguimento no HC-UFMG. Ver. Ass Med Brasil, 46(4), 325-330. https://www.scielo.br/j/ramb/a/vtnrzgpd3ngg78fmwn7zfjd/?format=pdf&lang=pt
Rosenfeld, M., Davis, R., Fitzsimmons, S., Pepe, M. & Ramsey, B.(1997). Gender gap in cystic fibrosis mortality, American Journal of Epidemiology , 145(9),794–803. https://doi.org/10.1093/oxfordjournals.aje.a009172
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.
Sanders, D. B., & Fink, A. K. (2016). Background and epidemiology. Pediatric Clinics of North America, 63(4), 567–584. https://doi.org/10.1016/j.pcl.2016.04.001
Santo, A. H., & Silva-Filho, L. V. R. F. Da. (2021). Tendências de mortalidade relacionada à fibrose cística no brasil no período de 1999 a 2017: um estudo de causas múltiplas de morte. Jornal Brasileiro de Pneumologia, 47, E20200166. https://www.scielo.br/j/jbpneu/a/qdplc56nyt8gpdqn8bt3fzd/?lang=pt#
Turcios N. L. (2020). Cystic fibrosis lung disease: an overview. Respiratory CARE, 65(2), 233–251. https://doi.org/10.4187/respcare.06697
Wielpütz, M. O., Eichinger, M., Biederer, J., Wege, S., Stahl, M., Sommerburg, O., Mall, M. A., Kauczor, H. U., & Puderbach, M. (2016). Imaging of cystic fibrosis lung disease and clinical interpretation. Bildgebung der lunge bei mukoviszidose und klinische interpretation. ROFO : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, 188(9), 834–845. https://doi.org/10.1055/s-0042-104936
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anderson Quadros de Alcântara; Milena Marques da Costa; Marcelle dos Santos Alusiar; Láysa Rodrigues de Lima Gomes; Lauanda Rodrigues de Lima Gomes; Lorena de Oliveira Tannus; Danillo dos Santos Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
